View in EDS

Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes.

Saved in:
Bibliographic Details
Title: Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes.
Authors: Taha OS; Department of Clinical Biochemistry, School of Medicine Cellular & Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran., Azami G; Department of Emergency Medical Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran., Saed L; Department of Endocrinology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran., Hakhamaneshi MS; Department of Clinical Biochemistry, School of Medicine Cellular & Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. biohakha@gmail.com., Moridi H; Department of Laboratory Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran. hereshmoridi@yahoo.com.
Source: BMC endocrine disorders [BMC Endocr Disord] 2026 May 23; Vol. 26 (1). Date of Electronic Publication: 2026 May 23.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823 (Electronic) Linking ISSN: 14726823 NLM ISO Abbreviation: BMC Endocr Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42177445
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Taha+OS%22">Taha OS</searchLink>; Department of Clinical Biochemistry, School of Medicine Cellular & Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.<br /><searchLink fieldCode="AU" term="%22Azami+G%22">Azami G</searchLink>; Department of Emergency Medical Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran.<br /><searchLink fieldCode="AU" term="%22Saed+L%22">Saed L</searchLink>; Department of Endocrinology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.<br /><searchLink fieldCode="AU" term="%22Hakhamaneshi+MS%22">Hakhamaneshi MS</searchLink>; Department of Clinical Biochemistry, School of Medicine Cellular & Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. biohakha@gmail.com.<br /><searchLink fieldCode="AU" term="%22Moridi+H%22">Moridi H</searchLink>; Department of Laboratory Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran. hereshmoridi@yahoo.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101088676%22">BMC endocrine disorders</searchLink> [BMC Endocr Disord] 2026 May 23; Vol. 26 (1). <i>Date of Electronic Publication: </i>2026 May 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101088676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-6823 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214726823%22">14726823 </searchLink><i>NLM ISO Abbreviation: </i>BMC Endocr Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42177445
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12902-026-02320-z
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Taha OS
      – PersonEntity:
          Name:
            NameFull: Azami G
      – PersonEntity:
          Name:
            NameFull: Saed L
      – PersonEntity:
          Name:
            NameFull: Hakhamaneshi MS
      – PersonEntity:
          Name:
            NameFull: Moridi H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 05
              Text: 2026 May 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1472-6823
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC endocrine disorders
              Type: main
ResultId 1